GW768505A free base (C007B-357826)

Catalog No.: C007B-357826
Mfr. No.: G650427-50mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $1,338.93

List Price: $1,487.70

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

GW768505A free base is a potent dual inhibitor of VEGFR2 (KDR) and Tie-2 , with a p IC 50 of 7.81 for VEGFR2. GW768505A free base has anti-angiogenic activity.In VitroGW768505A free base has inhibition for cancer cells growth in NCI-60 panel screening. GW768505A free base is an inhibitor of KDR and TIE2, shows potent inhibition (71–88% inhibition at 100 nM) of the tropomysin-related kinases TRKA, TRKB and TRKC. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:KDR Tie2 Tie-2. Specification: 0.98 Molecular Formula: C27H20ClF4N5O3 Molecular Weight: 573.93 PubChem CID: 5326956 Isomeric SMILES: COC1=CC=C(C=C1)C2=C(C3=C(N=CN=C3O2)N)C4=CC=C(C=C4)NC(=O)NC5=C(C=CC(=C5)C(F)(F)F)F

UPC:: 51112000
Condition:: New
Availability:: 8-12 weeks
Weight:: 1.06 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: G650427-50mg
CAS:: 501693-25-0
Product Size:: 50mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."